Skip to content

A phase II trial of the efficacy and safety of boring biopsy with rapid on-site evaluation for histological diagnosis of gastric mesenchymal tumor

A phase II trial of the efficacy and safety of boring biopsy with rapid on-site evaluation for histological diagnosis of gastric mesenchymal tumor - A phase II trial of the efficacy and safety of boring biopsy with rapid on-site evaluation for histological diagnosis of gastric mesenchymal tumor

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045414
Enrollment
22
Registered
2021-09-08
Start date
2021-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric mesenchymal tumor

Interventions

None listed

Sponsors

Osaka International Cancer Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Primary registration eligibility criteria: -Patients who will undergo endoscopic ultrasonography for gastric submucosal tumors. -The age at the time of registration is 20 years or older. -Performance status is ECOG 0-2. -Written consent has been obtained from the patient for participation in the study. Secondary registration eligibility criteria: -Endoscopic ultrasonography shows that the lesion is a hypoechoic mass with a diameter of 20 mm or more that is continuous with the 4th layer.

Exclusion criteria

Exclusion criteria: -The lesion is difficult to recognize by white light endoscopy. -The Lesion is present in the cardia.

Design outcomes

Primary

MeasureTime frame
Percentage of cases diagnosed with GIST

Countries

Japan

Contacts

Public ContactTakashi Kanesaka

Osaka International Cancer Institute Department of Gastrointestinal Oncology

takashikanesaka@gmail.com+81-6-6945-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026